Related Experiment Video
Updated: Jun 12, 2025
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Multivariate analysis of metabolic state vulnerabilities across diverse cancer contexts reveals synthetically lethal
Cara Abecunas1, Audrey D Kidd2, Ying Jiang3
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies.
Insights
Cancer cells have unique metabolic needs, but their diversity makes treatment difficult. This study identifies specific metabolic states in tumors, revealing vulnerabilities and potential new cancer therapies targeting tumor metabolism.
Area of Science:
- Oncology
- Metabolomics
- Systems Biology
Background:
- Targeting cancer cell metabolism is a promising therapeutic strategy.
- The heterogeneity of cancer metabolism presents challenges for effective treatment development.
- Understanding tumor-specific metabolic states is crucial for precision medicine.
Purpose of the Study:
- To systematically identify recurrent metabolic states in cancer cell lines.
- To associate metabolic states with tumor lineage, growth environments, and genetic context.
- To uncover metabolic vulnerabilities for targeted cancer therapies.
Main Methods:
- Utilized unsupervised and supervised multivariate modeling on hundreds of cancer cell lines.
- Validated findings using patient-derived tumor data and pharmacological screens.
- Performed genetic and pharmacological experiments to confirm key associations.
Main Results:
- Identified distinct, recurrent metabolic states across diverse cancer cell lines.
- Established links between metabolic states, tumor lineage, and genetic drivers (e.g., PTEN loss).
- Uncovered synthetically lethal interactions between metabolic states (e.g., oxidative phosphorylation) and therapeutic targets (e.g., mitochondrial electron transport chain).
Conclusions:
- Cancer cell metabolism is diverse but can be categorized into recurrent states.
- Specific metabolic states are associated with genetic alterations and confer vulnerabilities.
- These findings support the development of precise, metabolism-targeted cancer therapies.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Related Concept Videos
01:21Cancer Survival Analysis
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...